We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$54B
AUM Growth
-$3.2B
Cap. Flow
-$865M
Cap. Flow %
-1.6%
Top 10 Hldgs %
28.71%
Holding
986
New
116
Increased
314
Reduced
359
Closed
149

Top Buys

Rank Stock Value
1
HUBB icon
Hubbell
HUBB
+$244M
2
NSC icon
Norfolk Southern
NSC
+$149M
3
INSM icon
Insmed
INSM
+$138M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131M
5
DHR icon
Danaher
DHR
+$119M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$340M
2
BMY icon
Bristol-Myers Squibb
BMY
+$339M
3
UNP icon
Union Pacific
UNP
+$191M
4
MCD icon
McDonald's
MCD
+$190M
5
HES
Hess
HES
+$168M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Healthcare 14.99%
3 Financials 12.56%
4 Consumer Discretionary 9.54%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNG icon
901
Cheniere Energy
LNG
$55.7B
-65,000
Closed -$14M
LRMR icon
902
Larimar Therapeutics
LRMR
$436M
-2,100,000
Closed -$8.13M
MIR icon
903
Mirion Technologies
MIR
$3.74B
-140,958
Closed -$2.46M
MLTX icon
904
MoonLake Immunotherapeutics
MLTX
$1.53B
-155,000
Closed -$8.39M
MP icon
905
MP Materials
MP
$8.45B
-149,437
Closed -$2.33M
MRUS
906
DELISTED
Merus
MRUS
-250,000
Closed -$10.5M
MTH icon
907
Meritage Homes
MTH
$4.71B
-130,000
Closed -$10M
NCLH icon
908
Norwegian Cruise Line
NCLH
$8.89B
-410,800
Closed -$10.6M
NLY icon
909
Annaly Capital Management
NLY
$17.1B
-900,000
Closed -$16.5M
NPWR.WS icon
910
NET Power Inc Warrants
NPWR.WS
$13.1M
-20,000
Closed -$72K
NVCR icon
911
NovoCure
NVCR
$1.83B
-200,000
Closed -$5.96M
NWN icon
912
Northwest Natural Holdings
NWN
$2.14B
-241,242
Closed -$9.54M
OLMA icon
913
Olema Pharmaceuticals
OLMA
$1.03B
-365,198
Closed -$2.13M
OMC icon
914
Omnicom Group
OMC
$22.6B
-31,410
Closed -$2.7M
ORIC icon
915
Oric Pharmaceuticals
ORIC
$1.34B
-500,000
Closed -$4.04M
PEG icon
916
Public Service Enterprise Group
PEG
$37.4B
-640,484
Closed -$54.1M
PINS icon
917
Pinterest
PINS
$13.2B
-250,000
Closed -$7.25M
PLBC icon
918
Plumas Bancorp
PLBC
$428M
-4,693
Closed -$222K
PLRX icon
919
Pliant Therapeutics
PLRX
$65M
-649,660
Closed -$8.56M
PR
920
Permian Resources
PR
$17B
-45,000
Closed -$647K
RCUS icon
921
Arcus Biosciences
RCUS
$3.56B
-443,000
Closed -$6.6M
RGA icon
922
Reinsurance Group of America
RGA
$15.5B
-100,000
Closed -$21.4M
RGNX icon
923
Regenxbio
RGNX
$722M
-500,000
Closed -$3.87M
RGLS
924
DELISTED
Regulus Therapeutics
RGLS
-2,000,000
Closed -$3.16M
RL icon
925
Ralph Lauren
RL
$23.6B
-22,126
Closed -$5.11M

Similar funds

Adage Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adage Capital Partners held 986 positions worth $54B, down 5.6% from $57.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners's Q1 2025 filing shows 116 new, 314 increased, 359 reduced and 149 closed positions. Its largest new stake was Diamondback Energy: 485,503 shares worth $77.6M. The largest sale was Royalty Pharma, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2025 buy was Diamondback Energy: 485,503 shares worth $77.6M.
  • Adage Capital Partners added most to Hubbell in Q1 2025, an estimated $244M increase.
  • Adage Capital Partners's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $340M.
  • Adage Capital Partners fully exited Geron in Q1 2025, selling an estimated $77.2M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $54B portfolio in Q1 2025.
  • Adage Capital Partners opened 116 new positions and closed 149 in Q1 2025.
  • Adage Capital Partners's portfolio value fell 5.6% quarter-over-quarter to $54B.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.